Angela Vidal-Rynne
Madrid, MD 28049, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Prostaglandin F2α-induced prostate transmembrane protein, androgen induced 1 mediates ovarian cancer progression increasing epithelial plasticity" [Neoplasia 21 (2019) 1073-1084].
Journal: Neoplasia (New York, N.Y.)
Published: April 19, 2020
Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity.
Journal: Neoplasia (New York, N.Y.)
Published: June 21, 2019
Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
Journal: Nature communications
Published: July 25, 2018
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Journal: The Journal of pathology
Published: October 21, 2016
Mesothelial-to-mesenchymal transition in the pathogenesis of post-surgical peritoneal adhesions.
Journal: The Journal of pathology
Published: August 26, 2015
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.
Journal: Cancers
Published: August 07, 2015
Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
Journal: The Journal of pathology
Published: April 04, 2013
Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.
Journal: PloS one
Published: October 24, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026